Century Therapeutics, Inc. (IPSC)
1.53
-0.08
(-4.97%)
USD |
NASDAQ |
Oct 02, 16:00
1.53
0.00 (0.00%)
After-Hours: 20:00
Century Therapeutics Price to Book Value : 1.189 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.189 |
| October 01, 2026 | 1.251 |
| September 30, 2026 | 1.329 |
| September 29, 2026 | 1.282 |
| September 28, 2026 | 1.298 |
| September 25, 2026 | 1.298 |
| September 24, 2026 | 1.313 |
| September 23, 2026 | 1.368 |
| September 22, 2026 | 1.469 |
| September 21, 2026 | 1.438 |
| September 18, 2026 | 1.445 |
| September 17, 2026 | 1.461 |
| September 16, 2026 | 1.445 |
| September 15, 2026 | 1.539 |
| September 14, 2026 | 1.554 |
| September 11, 2026 | 1.508 |
| September 10, 2026 | 1.508 |
| September 09, 2026 | 1.577 |
| September 08, 2026 | 1.608 |
| September 04, 2026 | 1.640 |
| September 03, 2026 | 1.624 |
| September 02, 2026 | 1.640 |
| September 01, 2026 | 1.577 |
| August 31, 2026 | 1.593 |
| August 28, 2026 | 1.574 |
| Date | Value |
|---|---|
| August 27, 2026 | 1.733 |
| August 26, 2026 | 1.663 |
| August 25, 2026 | 1.686 |
| August 24, 2026 | 1.647 |
| August 21, 2026 | 1.608 |
| August 20, 2026 | 1.570 |
| August 19, 2026 | 1.640 |
| August 18, 2026 | 1.523 |
| August 17, 2026 | 1.515 |
| August 14, 2026 | 1.492 |
| August 13, 2026 | 1.500 |
| August 12, 2026 | 1.523 |
| August 11, 2026 | 1.601 |
| August 10, 2026 | 1.539 |
| August 07, 2026 | 1.554 |
| August 06, 2026 | 1.476 |
| August 05, 2026 | 1.523 |
| August 04, 2026 | 1.562 |
| August 03, 2026 | 1.539 |
| July 31, 2026 | 1.570 |
| July 30, 2026 | 1.702 |
| July 29, 2026 | 1.570 |
| July 28, 2026 | 1.593 |
| July 27, 2026 | 1.624 |
| July 24, 2026 | 1.640 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tenax Therapeutics, Inc. | 0.5569 |
| Exicure, Inc. | 7.502 |
| Absci Corp. | 7.716 |
| Celularity, Inc. | -- |
| Cardio Diagnostics Holdings, Inc. | 0.7811 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0078 |
| Price | 1.53 |
| Earnings Yield | -58.62% |
| Market Cap | 276.24M |
| PEGY Ratio | -0.0078 |